Related Experiment Videos
Past major depression and smoking cessation outcome: a systematic review and meta-analysis update
Brian Hitsman1, George D Papandonatos, Dennis E McChargue
1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. b-hitsman@northwestern.edu
Aims:
To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome.
Methods:
Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association.
Results:
MD+ smokers had 17% lower odds of short-term abstinence (n = 35, OR = 0.83, 95% CI = 0.72-0.95, P = 0.009) and 19% lower odds of long-term abstinence (n = 38, OR = 0.81, 95% CI = 0.67-0.97, P = 0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors.
Conclusions:
Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.
Insights
Individuals with a history of major depression (MD+) experience a modest decrease in smoking cessation success rates. Effective treatments are needed to address this disparity in smoking cessation outcomes for MD+ smokers.
Area of Science:
- Psychiatry
- Addiction Medicine
- Behavioral Science
Background:
- Past major depression (MD+) has been previously suggested to be unrelated to smoking cessation outcomes.
- However, updated analyses are necessary to confirm or refute this association.
Purpose of the Study:
- To update a prior meta-analysis on the relationship between past major depression and smoking cessation.
- To investigate potential moderators influencing this association.
Main Methods:
- An updated systematic review identified 28 eligible trials in addition to 14 from a previous review.
- Analyses focused on placebo/lowest intensity control arms to minimize the influence of experimental treatments.
- Study-specific odds ratios (ORs) for abstinence were estimated and combined using random effects models.
Main Results:
- Smokers with a history of major depression (MD+) showed 17% lower odds of short-term abstinence and 19% lower odds of long-term abstinence compared to those without (MD-).
- These associations were influenced by methodological factors (e.g., recent major depressive episode exclusion) and treatment characteristics (e.g., cognitive behavioral treatment modality).
Conclusions:
- Past major depression exerts a modest adverse effect on smoking cessation abstinence.
- There is a need for enhanced identification of effective treatments or adaptations to eliminate disparities in smoking cessation for individuals with a history of major depression.
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Depressive Disorders: MDD and Dysthymia
CNS Depressants: Alcohol and Nicotine